Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-04-23 @ 8:08 PM
Study NCT ID:
NCT03043950
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2017-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE)
Sponsor:
iOMEDICO AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-02
First Submit QC Date:
None
Study First Post Date:
2017-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-23
Last Update Post Date:
2024-04-24
Last Update Post Date Type:
ACTUAL